A thermodynamic assay to test pharmacological chaperones for Fabry disease. - Wikidata - wikimedia - TriplyDB

A thermodynamic assay to test pharmacological chaperones for Fabry disease.

A thermodynamic assay to test pharmacological chaperones for Fabry disease.

http://www.wikidata.org/entity/Q37539884

about

Identification of an Allosteric Binding Site on Human Lysosomal Alpha-Galactosidase Opens the Way to New Pharmacological Chaperones for Fabry Disease Using pharmacological chaperones to restore proteostasis The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations Taming molecular flexibility to tackle rare diseases.Looking for protein stabilizing drugs with thermal shift assay.Effects of ligand binding on the stability of aldo-keto reductases: Implications for stabilizer or destabilizer chaperones.E-Learning for Rare Diseases: An Example Using Fabry Disease.In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease.

P2860

Q28553021-64C50210-53DE-4076-A22D-148AE31DC929 Q33804655-F65A88EF-C098-488A-8D62-2C64DD1C2E3C Q36213022-4714A8E4-4D52-4142-BBE8-65FE3B8C3033 Q40960071-301E2091-5917-49FB-9467-44C8F12B270A Q41112024-1D6BD988-E52D-4F10-B43D-6090F861A3FF Q42364703-896F8A11-6FE7-4E03-8848-638E1275AEE0 Q47147113-A8B57443-C63E-4E4B-90C5-CEAE447F2C20 Q49497813-B34A1447-E581-4CB5-AC34-716EE82EAF15

P2860

A thermodynamic assay to test pharmacological chaperones for Fabry disease.

http://www.wikidata.org/entity/Q37539884

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A thermodynamic assay to test pharmacological chaperones for Fabry disease.

@en

A thermodynamic assay to test pharmacological chaperones for Fabry disease.

@nl

type

label

A thermodynamic assay to test pharmacological chaperones for Fabry disease.

@en

A thermodynamic assay to test pharmacological chaperones for Fabry disease.

@nl

prefLabel

A thermodynamic assay to test pharmacological chaperones for Fabry disease.

@en

A thermodynamic assay to test pharmacological chaperones for Fabry disease.

@nl

P1433

Q37539884-5E3B7FA0-21B0-4A43-B0B6-C9DB732A57DE

P1476

Q37539884-334FF384-A733-489B-9BBD-748A0C4C74A6

P2093

Q37539884-1E8EE0B4-D28F-4B8D-B40A-3A3C664F6488

Q37539884-E2AA19B2-5A2B-4B82-9C75-EF1E72252874

P2860

Q37539884-03236868-4DB2-4ED3-A9E8-163B36916656

Q37539884-1741BC65-CD5B-4958-9CCE-57CFF84FF6E4

Q37539884-1A89BE25-8F4A-4F14-ACD7-96D7CB70F9E2

Q37539884-1EA5BBA6-1B40-496B-A506-61FFED2A38CB

Q37539884-1F7BB6C0-18A4-4857-9069-C02414AAAE10

Q37539884-247E6A85-74A5-478B-B9F5-EB273CA33739

Q37539884-2D992E65-91E9-46E5-8D76-CF384C01DDDA

Q37539884-314C00C0-5738-4FD9-89DC-E1F681DF2FD6

Q37539884-343F9827-50FF-48C0-A1AB-2C0891ABDC0B

Q37539884-35539792-0EF7-47F0-A2EC-31273FB8C1BC

P304

Q37539884-12947B5D-2B78-45D9-B1C8-F3C5F6848F5D

P31

Q37539884-EEA03430-0477-4E63-BD16-8D8284E4A39C

P356

Q37539884-DCD994A5-3495-4B42-A5A8-3C9B1682049F

P407

Q37539884-69BE0147-1A9F-44E1-B157-FC01B1B893B4

P433

Q37539884-2D47D2B2-5DCD-4B84-BF0C-7A36A297AE36

P478

Q37539884-1EA4DC2D-1D30-497F-9721-05B52FFA4688

P50

Q37539884-7D5D9723-27C2-4704-802B-C4237EA06606

Q37539884-DC5BD390-58AB-4782-8763-21BFEDFF4BB7

P577

Q37539884-617B2E00-7790-4AD7-B322-7733A416A339

P5875

Q37539884-45E51813-7435-468D-B704-F6A22AD9F548

P698

Q37539884-A1BD59C0-91F5-4137-A9A3-E4C020084909

P921

Q37539884-2E0E01CC-C400-42E4-829F-37A66B6AC60C

Q37539884-92BA0E5A-7675-4C0B-9D78-5CD53491EEA2

P932

Q37539884-78621F52-1559-4590-A59E-C08766A1F2D6

P356

J.BBAGEN.2013.12.018

P1433

Biochimica et Biophysica Acta

P1476

A thermodynamic assay to test pharmacological chaperones for Fabry disease

@en

P2093

Antonella Correra

http://www.w3.org/2001/XMLSchema#string

Valentina Citro

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and Stability

The Molecular Basis of Pharmacological Chaperoning in Human α-Galactosidase

Loss of protein structure stability as a major causative factor in monogenic disease.

The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.

Novel pharmacological chaperones that correct phenylketonuria in mice.

Fabry disease: twenty novel alpha-galactosidase A mutations causing the classical phenotype.

Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies.

The pharmacological chaperone AT2220 increases recombinant human acid α-glucosidase uptake and glycogen reduction in a mouse model of Pompe disease.

P304

1214-1224

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBAGEN.2013.12.018

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1840

http://www.w3.org/2001/XMLSchema#string

P50

Maria Vittoria Cubellis

Giuseppina Andreotti

P577

2013-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259448326

http://www.w3.org/2001/XMLSchema#string

P698

24361605

http://www.w3.org/2001/XMLSchema#string

P921

molecular chaperones

P932

3909460

http://www.w3.org/2001/XMLSchema#string